chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PERIPHERAL NEUROPATHY 12/16/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Pt had PNEUMOVAX on 10/14/17 w/o complaints. Then patient came in on 10/15/17 at 10:15 am when we opened complaining of soreness, redness and a rash. I recommended BENADRYL and a compress and told her to go to urgent care if no better. I called pt back on Monday and the soreness and swelling went down. She said she felt fine. I wrote up an incident report and VAERS per protocol. I suspected an allergy, so I also contacted Dr - left message on voicemail, but have yet to get any more response. I updated the file for PNEUMOVAX as an allergy.
Bone pain; Feels cold; Then gets hot; It has been a lousy week; Bad rash; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bone pain), FEELING COLD (Feels cold), FEELING HOT (Then gets hot), FEELING ABNORMAL (It has been a lousy week) and RASH (Bad rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 013A219 and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2021, the patient experienced BONE PAIN (Bone pain), FEELING COLD (Feels cold), FEELING HOT (Then gets hot), FEELING ABNORMAL (It has been a lousy week), RASH (Bad rash) and MYALGIA (Muscle pain). At the time of the report, BONE PAIN (Bone pain), FEELING COLD (Feels cold), FEELING HOT (Then gets hot), FEELING ABNORMAL (It has been a lousy week), RASH (Bad rash) and MYALGIA (Muscle pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
fever of 102 for 4 days and then developed a rash with blisters on his head/ neck and left leg. The blister/rash on his head and neck have still not healed completely ( red and itchy)
Horrible cramping following day from 3 AM- 10 PM. Admitted to hospital to ensure baby was ok.
Patient presented for covid 19 vaccine 1/7/2021. Vaccine given at 11:11 AM. Patient asked to wait 30 min. after injection due policy in place. At 11:14AM patient states "is it hot in here, I feel dizzy"  Patient assisted to the floor, legs elevated. That is when patient began to shake. BP 142/78 O2 94 Pulse 111. Patient was responsive but unable to open eyes and answer questions, nodding appropriately to questions given by Provider on staff. Provider called to scene. Provider assessed patient, stridor noticed by Provider and 0.3mg of Epi given by IM. EMS was called to clinic. At 11:19AM BP 142/78. EMS arrived at 11:23AM and stayed with patient, no change in status. EMS took patient to hospital. Patient discharged same day and per patient "doing well other than sore and tired".
Child's mother called 8/29/19 at 9:15 am to report child had experienced a reaction to one of the vaccines, she was looking to find out which vaccine was given in the left arm in the area below the shoulder and not at the back of the arm. *this was the DTaP*. Mother reports the day after the vaccines was given (Tuesday) she noted some redness at the injection site, he also had a mild fever that night 100.4 and did experience vomiting. She report Wednesday the redness had progressed to be from the shoulder to the elbow, and that the area of the injection looked bruised, and she now noted swelling from the shoulder to the elbow. Child reports pain in arm but also generalized pain, neck, back, legs, and stomach with associated vomiting and decreased appetite. Mom reports that she has not taken the child to see his provider yet. This nurse strongly encouraged she get the child in to see his provider as soon as possible, guided mom to be sure to report the severity of the symptoms to doctor when calling to schedule as he should be seen today. Read through the VIS with the mother, outlining the information in the "Risk of Vaccine Reaction" section which does indicate that this type of swelling can occur but it is more rare. Did discuss alternative rare reactions which could include abscess at the site of injection. Again, strongly encouraged she get the child in to be evaluated by his provider.
Information was received on 12-SEP-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age.  Medical history, concurrent conditions, and concomitant medications were not provided. It was reported that the patient was vaccinated with a dose of ZOSTAVAX (lot number, dosage, and route of administration not provided) on or about 21-MAY-2012 at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent and chronic strain of herpes zoster. On or about 27-JUL-2016, the patient was treated by a LPN for a painful outbreak that was diagnosed as herpes zoster, or shingles. On or about 30-JUL-2016, the patient was treated again for continued and worsening symptoms of shingles outbreaks and intense pain. The patient has been prescribed VALTREX for management of her painful symptoms and outbreaks. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
Awaken around 2:00 am with mild asthma symptoms wheezing and tight chest. Haven't been waken before at night and thought it was unusual.  Around 5:00pm that same day I noticed itchiness near the injection site and around the neck.  Around 6:00pm I noticed a muscle twitch around the elbow on the right arm.  By 7:00 pm my back, chest, and both arms were extremely itching.  I took a generic Benadryl and a puff of my Proventil inhaler.  This helped a little but I took another Benadryl an hour later.  I was able to sleep several hours later. Next morning sill have itchiness but less and asthma symptoms seem better.
Then 3 year old with PDD, mom feels that she noted a regression in behavior for 6 weeks after immunization.
Fever of 100.1, chills, body aches (Lower half of body only), headache, extreme fatigue. Missed work. Started at 4 am, about 18 hrs after vaccine given. Lasted 24 hrs.
she was sick for 2.5 - 3 days; felt like she had the flu she was quite sick; She had a 103 fever and was sort of like out of it; she was incoherent; Swollen lymph nodes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID.  A 75-year-old female patient received BNT162b2 (BNT162B2), on 19Oct2021 at 16:30 as dose 3 (booster), single (Lot number: EW0186) at the age of 75 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, 0.3 ML SINGLE, Lot number: EL3249, Expiry: unknown, NDC: unknown), administration date: 21Jan2021, when the patient was 74-year-old, for COVID-19 Immunization, reaction(s): "Fever"; BNT162b2 (DOSE 2, SINGLE, Lot number: EL9267, Expiry: unknown, NDC: unknown), administration date: 11Feb2021, when the patient was 74-year-old, for COVID-19 Immunization, reaction(s): "Fever". The following information was reported: PYREXIA (non-serious) with onset Oct2021, outcome "unknown", described as "She had a 103 fever and was sort of like out of it"; LYMPHADENOPATHY (non-serious) with onset Oct2021, outcome "unknown", described as "Swollen lymph nodes"; INFLUENZA LIKE ILLNESS (non-serious) with onset Oct2021, outcome "unknown", described as "felt like she had the flu she was quite sick"; INCOHERENT (non-serious) with onset Oct2021, outcome "unknown", described as "she was incoherent"; ILLNESS (non-serious) with onset 20Oct2021, outcome "recovered" (Oct2021), described as "she was sick for 2.5 - 3 days". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information:  Caller was reported for his wife that she had a 103 Fever with each one. The patient did get a fever the one time and she was incoherent. The patient had a 103 fever and was sort of like out of it. Caller then handed the phone over to his wife and wife then completed the rest of the report on herself. The patient said she was sick for 2.5 - 3 days. The patient reports having a fever after each dose, felt like she had the flu she was quite sick. Caller then stated she could not have her mammogram because of swollen lymph nodes from the covid Shot. She had to reschedule it for 8 weeks later. The first one she got the vaccine at 100:00am and 12 that night it started. The second time it was 12 hours or 13 hours later and then same thing booster, got it at 4:30pm and work up sick the next day as far as she can remember. Vaccination facility type it was at a Satellite office or doctor's office. The patient did not receive other vaccines within four weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had no family medical history. No additional vaccines administered on same date.
itchy; painful, swollen rash; painful, swollen rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (painful, swollen rash) and VACCINATION SITE RASH (painful, swollen rash) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (painful, swollen rash) and VACCINATION SITE RASH (painful, swollen rash). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (painful, swollen rash) and VACCINATION SITE RASH (painful, swollen rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Patient applied cold compress on the area with rash Concomitant medication information was not reported. Treatment information as not reported. .
Nurse administered ADACEL injection to pt 7-7-08 and pt already had ADACEL injection on 4-9-08.
This spontaneous report as received from a other health professional refers to a patient of unknown age. Medical history, current conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with VARIVAX lot # M008171, .5 ml, subcutaneous instead of intended ZOSTAVAX. Other suspect therapies included sterile diluent (lot number:N006322 expiry date:11-JUL-2019). No adverse effects were reported. No product quality complaint was reported. The outcome of wrong drug administered and no adverse event was unknown.
Face was swollen; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection), via an unspecified route of administration on 23Feb2021 (lot number was not reported) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported of having the vaccine on 23Feb2021 and was concerned since the patient's face was swollen on an unspecified date. The patient wanted to know what can be done to get it to go down. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Inactivated influenza. Sore to the touch. Right arm bump size of a dime at 8pm, 10/4. 7a 10/5 bump size of a quarter. 11 am school nurse called right arm swollen to a small egg. Applied ice pack. Muscle pain reported. Temp 100. TYLENOL given at 7 pm, 10/5. No fever or pain 10/6. Still sore, swelling almost gone. No swelling, tight muscle looking 4 am 10/7 and tender.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with improperly stored doses of ROTATEQ (lot number and expiry date unknown) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse event was reported. The action taken with the therapy with ROTATEQ was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with ROTATEQ was unknown. There was no product quality issue reported. This is one of the many reports received from the same source. Additional information has been requested.
This spontaneous report was received from a female patient of unknown age regarding herself. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date and route not reported). On an unknown date the patient experienced itching and warm lump around the ZOSTAVAX injection site. The outcome of the reported events were unknown. Causality was not reported. Additional information is not expected.
Pt told mother he wasn't feeling well, head hurt, light headed, passed out on floor, hit forehead right side on door frame. Pt woke up immediately, clammy skin. At 1415 BP 104/75, HR 75, R 20, Paris canal. At 1430 pt coherent BP 96/67, HR 71. Monitored pt for 30 min. Shot given 1355, passed out at 1400. Pt went home.
This spontaneous report was received from a healthcare professional (Nurse) refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 08-MAR-2019, the patient was vaccinated with improperly stored PNEUMOVAX 23 syringes (lot # R021048, expiry date: 14-APR-2020) for prophylaxis (product storage error). No adverse effect was reported. The vaccine was stored above 8 degree centigrade (10.0 degree centigrade) for 35 minutes, there was no previous temperature excursion. The outcome of product storage error and no adverse event was unknown.
1st dose Oct2019, has not received 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose intramuscularly on the arm (unknown), in October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 25-Mar-2022 Reporter's Comments: The case was self reported by the patient. The patient had nothing else to report. The reporter consented to follow up with herself and her physician. Additional Supportive Information: The patient had not received the second dose of Shingrix till time of reporting, which led to incomplete course of vaccination.
pt recv vax 18DEC95 & 17JUL97 pt devel chickenpox w/approx 100 vesicles;28JUL97 pt recovered;
Took 600mg of Ibuprofen (200mg x3) orally at 7:45AM, 30 minutes later while viewing a medical webinar at my desk at home, I suddenly noticed significant itching of my entire hands which quickly became reddened and progressively swollen as the itching sensation become more generalized within 10-15 minutes. I got up from my chair to go tell my wife but as I walked a few paces, I became extremely weak with visual 'closing in' as I barely prevented myself from collapsing to the floor / losing consciousness. At the same time my tongue was now thickened and malfunctioning making my spoken words to my wife almost unintelligible - all consistent with a CLASSIC ANAPHYLAXIS REACTION.  My wife helped me to the couch to recline where I carefully swallowed CHLORPHENIRAMINE 8MG, FAMOTIDINE 20MG; and 15 minutes later DIPHENHYDRAMINE 50MG (I did not have any Epinephrine available from prior 'bee sting kits'). At no time was my breathing impaired nor was there any audible wheezing or dyspnea. After ~45 minutes I was improving noticeably, and after ~2-3 hours I had made a 100% recovery with no sequelae thereafter. Although I had taken my routine morning medications several HOURS PRIOR, nevertheless, (after purchasing several vials of Epinephrine 1mg/1mL for protection in case of another reaction), after this event and over the succeeding days I re-added each of those medications separately / one-at-a-time to ensure that NONE of those was the offending agent - NO problems ensued. For obvious reasons, I have 100% AVOIDED ingesting Ibuprofen or other typical NSAIDs since this episode (although my routine single daily aspirin tablet has presented no problems). BOTTOM LINE: DESPITE HAVING USED IBUPROFEN 400MG OR 600MG PERHAPS 1-2 TIMES WEEKLY AS NEEDED FOR MUSCULOSKELETAL DISCOMFORT OVER MANY YEARS, NEVER UNTIL THIS ANAPHYLACTIC EPISODE 11 DAYS AFTER MY SECOND DOSE OF MODERNA'S COVID-19 VACCINE HAD THERE EVER BEEN ANY TYPE OF ADVERSE REACTION TO IBUPROFEN WHATSOEVER.
terrible sweating to the point where I almost wet a bed; Suspected COVID-19; fever of 101 F; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (terrible sweating to the point where I almost wet a bed), SUSPECTED COVID-19 (Suspected COVID-19) and PYREXIA (fever of 101 F) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Leukemia since an unknown date and Coronavirus test positive in July 2020. Concomitant products included GABAPENTIN, TAMSULOSIN, IBRUTINIB (IMBRUVICA), ATORVASTATIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), GLIPIZIDE, ZINC and ASCORBIC ACID (VITAMIN C ACID).    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 24-Feb-2021, the patient experienced HYPERHIDROSIS (terrible sweating to the point where I almost wet a bed), SUSPECTED COVID-19 (Suspected COVID-19) and PYREXIA (fever of 101 F). On 25-Feb-2021, HYPERHIDROSIS (terrible sweating to the point where I almost wet a bed), SUSPECTED COVID-19 (Suspected COVID-19) and PYREXIA (fever of 101 F) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (terrible sweating to the point where I almost wet a bed), PYREXIA (fever of 101 F) and INFLUENZA LIKE ILLNESS (He felt like he had a Covid symptoms) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included GABAPENTIN, TAMSULOSIN, IBRUTINIB (IMBRUVICA), ATORVASTATIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), GLIPIZIDE, ZINC and ASCORBIC ACID (VITAMIN C ACID).    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 24-Feb-2021, the patient experienced HYPERHIDROSIS (terrible sweating to the point where I almost wet a bed), PYREXIA (fever of 101 F) and INFLUENZA LIKE ILLNESS (He felt like he had a Covid symptoms). On 25-Feb-2021, HYPERHIDROSIS (terrible sweating to the point where I almost wet a bed), PYREXIA (fever of 101 F) and INFLUENZA LIKE ILLNESS (He felt like he had a Covid symptoms) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient received Dose number 2 of the series at day 14. Pt states she is experiencing  H/a today 8/ and body aches. on 8/2 experienced fever chills. Taking Tylenol and Advil
Mylagia, fever, chills, status post Td booster on 10/06/01 for injury to index finger. PE showed 12 cm area . Inflamation and induration of right deltoid site. On 10/9/01 dx of cellulitis made and treated with Keflex. By 10/16/01 clinically improving.  Follow up 12/14/2001: "Contact hospital medical records department."
This spontaneous report was received from a Licensed Practical Nurse regarding unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On multiple unspecified dates, multiple unspecified patients were vaccinated with improperly stored PEDVAXHIB (dose strength, route and lot number was unknown). No concomitant medication was reported. No adverse event was reported. No product quality complaint (PQC) was involved. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
PT c/o scratchy throat, mild swelling of tongue. No SOB, no rash. PT took oral diphenhydramine, monitored in office until 7:30 PM. PT reported improvement before leaving office and at telephone F/U @9:00 PM, but did report welts on back. Phone F/U 8/7/2014:1130, PT reports welts on back still present and feels elevated heart rate.
This spontaneous report as received from a 72 year old female patient regarding herself. No concurrent conditions and medical history were reported. On 23-SEP-2015 the patient was vaccinated with PNEUMOVAX 23, 0.5 ml (dosing regimen and frequency unknown) (lot number and expiry date unknown) as doctor recommended (details unspecified). Concomitant therapies included nitrofurantoin (manufacturer unknown). On 24-SEP-2015 (also reported as 5 hours after receiving PNEUMOVAX 23, the patient's arm where she received the injection started to hurt, the patient also experienced swelling in her arm where she received the injection, felt very nervous and was not sleeping well. On 24-SEP-2015 the patient's arm where she received the injection had a rash and was red and the patient experienced blood pressure fluctuation 20 points below and 20 points above. It was reported that the patient sought medical attention and visited an office. The patient was treated with oral BENADRYL for the events. The action taken with the therapy PNEUMOVAX 23 was unknown. The outcome of blood pressure fluctuation, poor quality sleep, vaccination site rash, vaccination site erythema, nervousness, vaccination site swelling and vaccination site pain was reported as recovering. The relatedness of the events to the therapy with PNEUMOVAX 23 was unknown. There was no product quality issue reported. Additional information is not expected.